Effect of bisphosphonates in osteoporosis secondary to LHRH analogs for prostate cancer.

被引：0
|
作者：
Yaturu, S [1 ]
DePrisco, C [1 ]
DjoDjo, S [1 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, Overton Brooks VAMC, Shreveport, LA 71105 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M354
引用
收藏
页码：S474 / S474
页数：1
相关论文
共 50 条
  • [41] Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study
    Morote, Juan
    Gomez-Caamano, Antonio
    de Celis, Raul Poza
    Gomez-Veiga, Francisco
    Ciria, Juan P.
    Calleja, Jesus
    Extramiana, Javier
    Perez-Sampietro, Maria
    Perrot, Valerie
    Angulo, Javier C.
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (08) : 1824 - 1833
  • [42] LHRH agonist therapy causes early bone loss in men receiving treatment for prostate cancer.
    Taxel, P
    Albertsen, PC
    Dowsett, RJ
    Fall, PM
    Trahiotis, M
    Raisz, LG
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S64 - S64
  • [43] LHRH analog therapy causes early bone loss in men receiving treatment for prostate cancer.
    Taxel, P
    Albertsen, PC
    Dowsett, R
    Fall, PM
    Trahiotis, M
    Zimmermann, J
    Raisz, LG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S217 - S217
  • [44] Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer
    May Hagiwara
    Thomas E. Delea
    Ze Cong
    Karen Chung
    Supportive Care in Cancer, 2014, 22 : 103 - 113
  • [45] The role of bisphosphonates as adjuvant therapy for breast cancer.
    Gralow J.R.
    Current Oncology Reports, 2001, 3 (6) : 506 - 515
  • [46] Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer
    Hagiwara, May
    Delea, Thomas E.
    Cong, Ze
    Chung, Karen
    SUPPORTIVE CARE IN CANCER, 2014, 22 (01) : 103 - 113
  • [47] Effect of bisphosphonates on renal function in patients with osteoporosis
    Gifre, L.
    Peris, P.
    Monegal, A.
    Martinez-Ferrer, A.
    Hernandez, M. V.
    Guanabens, N.
    EUROPEAN GERIATRIC MEDICINE, 2013, 4 (06) : 380 - 383
  • [48] PROSTATE CANCER Making the switch from LHRH antagonist to LHRH agonist
    Moul, Judd W.
    NATURE REVIEWS UROLOGY, 2012, 9 (03) : 125 - 126
  • [49] Bisphosphonates in the management of metastatic prostate cancer
    Heidenreich, A
    ONCOLOGY, 2003, 65 : 5 - 11
  • [50] The potential role of bisphosphonates in prostate cancer
    G M Oades
    J Coxon
    K W Colston
    Prostate Cancer and Prostatic Diseases, 2002, 5 : 264 - 272
12345